Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study.
Saved in:
| Title: | Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study. |
|---|---|
| Authors: | Sundy JS (AUTHOR), Becker MA (AUTHOR), Baraf HSB (AUTHOR), Barkhuizen A (AUTHOR), Moreland LW (AUTHOR), Huang W (AUTHOR), Waltrip RW II (AUTHOR), Maroli AN (AUTHOR), Horowitz Z (AUTHOR), Pegloticase Phase 2 Study Investigators (CORPORATE AUTHOR) |
| Source: | Arthritis & Rheumatism. Sep2008, Vol. 58 Issue 9, p2882-2891. 10p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
